Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents

Br J Haematol. 2017 Nov;179(3):511-513. doi: 10.1111/bjh.14230. Epub 2016 Jul 8.

Authors

Sean Platton¹, Louise Bowles¹, Peter MacCallum^{2

3}

Affiliations

¹ Haemophilia Centre, Barts Health NHS Trust, Royal London Hospital, London, UK.
² Queen Mary's School of Medicine and Dentistry, London, UK.
³ Wolfson Institute of Preventive Medicine, London, UK.

PMID: 27392166
DOI: 10.1111/bjh.14230

No abstract available

Keywords: Coagulation; anticoagulants; haemostasis; laboratory haematology.

Publication types

Letter

MeSH terms

Blood Coagulation / drug effects*
Blood Coagulation Tests / methods
Blood Coagulation Tests / standards*
Factor Xa Inhibitors / adverse effects
Factor Xa Inhibitors / pharmacology*
Factor Xa Inhibitors / therapeutic use
Humans
Rivaroxaban / adverse effects
Rivaroxaban / pharmacology*
Rivaroxaban / therapeutic use
Venous Thrombosis / drug therapy
Venous Thrombosis / etiology

Substances

Factor Xa Inhibitors
Rivaroxaban